What is Lexicon Pharmaceuticals's other expenses?

Lexicon Pharmaceuticals (LXRX) reported other expenses of $1.59M in Q1 2026.

How has Lexicon Pharmaceuticals's other expenses changed year-over-year?

Lexicon Pharmaceuticals's other expenses decreased by 13.4% year-over-year, from $1.84M to $1.59M.

What is the long-term trend for Lexicon Pharmaceuticals's other expenses?

Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's other expenses has grown at a 79.6% compound annual growth rate (CAGR), from $802K to $8.34M.

Lexicon Pharmaceuticals LXRX Other expenses

Other expenses at other companies

Travel + LeisureTNL

$5M+150%

UnifirstUNF

$177K+233%

Dave, Inc.DAVE

$98.85M+35.7%

PennyMac Financial Services, Inc.PFSI

$440.29M+34.8%

Atmus Filtration TechnologiesATMU

-$6.1M-3,150%

Ryan Specialty HoldingsRYAN

$700.63M+18.8%

Segments

By segment

See full

Reportable Segment$1.59M-13.4%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherExpenses.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's other expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's other expenses?: Lexicon Pharmaceuticals (LXRX) reported other expenses of $1.59M in Q1 2026.
How has Lexicon Pharmaceuticals's other expenses changed year-over-year?: Lexicon Pharmaceuticals's other expenses decreased by 13.4% year-over-year, from $1.84M to $1.59M.
What is the long-term trend for Lexicon Pharmaceuticals's other expenses?: Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's other expenses has grown at a 79.6% compound annual growth rate (CAGR), from $802K to $8.34M.